External used medicine for treating chronic eczema

A technology for external medicine and stubborn tinea, applied in the field of medicine, can solve the problems of large side effects of medicine, severe skin damage, poor treatment effect, etc., and achieve the effects of rapid effect, long-lasting medicine effect and convenient administration.

Inactive Publication Date: 2011-04-06
党喜
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there are many kinds of medicines and methods for treating stubborn tinea. Western medicine focuses on sterilization and anti-inflammation for external use, and medicines such as aspirin and hormone are often used for oral administration. Severe, often leaving scars; traditional Chinese medicine treatment is mainly based on damp heat and dampness, expelling wind and relieving itching, the course of treatment is long, the curative effect is not obvious, and the effect of radical cure cannot be achieved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Weigh raw materials according to the following formula:

[0050] Hundred 100;

[0051] Bletilla striata 100;

[0052] Sichuan pepper 100;

[0053] Dafengzi 50;

[0054] Raw Aconitum 50;

[0055] Sulfur 50;

[0056] Salicylic acid 5;

[0057] ethanol 75.

[0058] After mixing and soaking for half a month, the finished product is obtained. In clinical use, it is applied to the affected part of the patient 3 to 4 times a day, and the healing effect is very good.

Embodiment 2

[0060] Weigh raw materials according to the following formula:

[0061] 100 80;

[0062] Bletilla striata 120;

[0063] Sichuan pepper 100;

[0064] Dafengzi 40;

[0065] Raw Aconitum 70;

[0066] Sulfur 30;

[0067] Salicylic acid 3;

[0068] Ethanol 80.

[0069] After mixing and soaking for half a month, the finished product is obtained. In clinical use, it is applied to the affected part of the patient 3 to 4 times a day, and the healing effect is very good.

Embodiment 3

[0071] Weigh raw materials according to the following formula:

[0072] 100 120;

[0073] Bletilla striata 100;

[0074] Sichuan pepper 80;

[0075] Dafengzi 40;

[0076] Raw Aconitum 50;

[0077] Sulfur 60;

[0078] Salicylic acid 7;

[0079] ethanol 65.

[0080] After mixing and soaking for half a month, the finished product is obtained. In clinical use, it is applied to the affected part of the patient 3 to 4 times a day, and the healing effect is very good.

[0081] Effect of the present invention is described below in conjunction with the clinical application record of the medicine that embodiment 1 makes again:

[0082] 1. Patient information

[0083] A total of 30 patients were tested, including 18 males and 12 females. In terms of disease distribution, there were 13 patients with neurodermatitis and tinea facial, 12 patients with tinea corporis, and 5 patients with tinea manus and pedis;

[0084] 2. How to use

[0085] Wash and dry the skin of the affected ar...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the medical technical field, in particular to an external-using medicine used for the treatment of stubborn dermatitis, which is prepared by mixing and soaking the following raw materials, and the raw materials expressed by weight account comprise: 80-120 portions of stemona root, 80-120 portions of stemona root, 80-120 portions of zanthoxylum pipertum DC, 30-70 portions of chaulmoogra, 30-70 portions of wild aconite root, 30-70 portions of sulfur, 3-8 portions of salicylic acid and 60-80 portions of ethanol. The external-using medicine used for the treatment of the stubborn dermatitis of the invention has new, advanced and unique raw material formula, and organically combined traditional Chinese medicines with western medicines. Furthermore, the invention has simple processing technique and applying method, innocuity and no side effect, fast drug effect and high cure rate.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating intractable tinea. Background technique [0002] Tinea disease is a common multiple skin disease. It is mostly caused by viruses, excessive cell proliferation, and low pigmentation resistance. It has the characteristics of high incidence, long course, difficult cure, and easy recurrence, which seriously affects people’s Physical health and quality of life. Persistent tinea includes psoriasis, neurodermatitis, tinea corporis, jock itch, tinea versicolor, tinea pedis, and the like. [0003] At present, there are many kinds of medicines and methods for treating stubborn tinea. Western medicine focuses on sterilization and anti-inflammation for external use, and medicines such as aspirin and hormone are often used for oral administration. severe, often leaving scars; traditional Chinese medicine treatment is mainly based on damp heat, dampness, expelling wi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/904A61P17/00A61P31/10A61K31/045A61K31/60A61K33/04
Inventor 党喜
Owner 党喜
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products